Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

Similar articles for PubMed (Select 23564351)

1.

Involvement of Gpr125 in the myeloid sarcoma formation induced by cooperating MLL/AF10(OM-LZ) and oncogenic KRAS in a mouse bone marrow transplantation model.

Fu JF, Yen TH, Chen Y, Huang YJ, Hsu CL, Liang DC, Shih LY.

Int J Cancer. 2013 Oct 15;133(8):1792-802. doi: 10.1002/ijc.28195. Epub 2013 May 7.

PMID:
23564351
2.

MLL/AF10(OM-LZ)-immortalized cells expressed cytokines and induced host cell proliferation in a mouse bone marrow transplantation model.

Fu JF, Hsu CL, Shih LY.

Int J Cancer. 2010 Apr 1;126(7):1621-9. doi: 10.1002/ijc.24867.

PMID:
19711340
3.

hDOT1L links histone methylation to leukemogenesis.

Okada Y, Feng Q, Lin Y, Jiang Q, Li Y, Coffield VM, Su L, Xu G, Zhang Y.

Cell. 2005 Apr 22;121(2):167-78. Erratum in: Cell. 2005 Jun 3;121(5):809.

4.

t(10;11)-acute leukemias with MLL-AF10 and MLL-ABI1 chimeric transcripts: specific expression patterns of ABI1 gene in leukemia and solid tumor cell lines.

Shibuya N, Taki T, Mugishima H, Chin M, Tsuchida M, Sako M, Kawa K, Ishii E, Miura I, Yanagisawa M, Hayashi Y.

Genes Chromosomes Cancer. 2001 Sep;32(1):1-10.

PMID:
11477655
5.

The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10.

DiMartino JF, Ayton PM, Chen EH, Naftzger CC, Young BD, Cleary ML.

Blood. 2002 May 15;99(10):3780-5.

6.

Development of a multi-step leukemogenesis model of MLL-rearranged leukemia using humanized mice.

Moriya K, Suzuki M, Watanabe Y, Takahashi T, Aoki Y, Uchiyama T, Kumaki S, Sasahara Y, Minegishi M, Kure S, Tsuchiya S, Sugamura K, Ishii N.

PLoS One. 2012;7(6):e37892. doi: 10.1371/journal.pone.0037892. Epub 2012 Jun 20.

7.

EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs.

Bindels EM, Havermans M, Lugthart S, Erpelinck C, Wocjtowicz E, Krivtsov AV, Rombouts E, Armstrong SA, Taskesen E, Haanstra JR, Beverloo HB, Döhner H, Hudson WA, Kersey JH, Delwel R, Kumar AR.

Blood. 2012 Jun 14;119(24):5838-49. doi: 10.1182/blood-2011-11-393827. Epub 2012 May 2.

8.

Flt3 does not play a critical role in murine myeloid leukemias induced by MLL fusion genes.

Albouhair S, Morgado E, Lavau C.

PLoS One. 2013 Aug 16;8(8):e72261. doi: 10.1371/journal.pone.0072261. eCollection 2013.

9.

Histone H2B ubiquitin ligase RNF20 is required for MLL-rearranged leukemia.

Wang E, Kawaoka S, Yu M, Shi J, Ni T, Yang W, Zhu J, Roeder RG, Vakoc CR.

Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):3901-6. doi: 10.1073/pnas.1301045110. Epub 2013 Feb 14.

10.

The clathrin-binding domain of CALM and the OM-LZ domain of AF10 are sufficient to induce acute myeloid leukemia in mice.

Deshpande AJ, Rouhi A, Lin Y, Stadler C, Greif PA, Arseni N, Opatz S, Quintanilla-Fend L, Holzmann K, Hiddemann W, Döhner K, Döhner H, Xu G, Armstrong SA, Bohlander SK, Buske C.

Leukemia. 2011 Nov;25(11):1718-27. doi: 10.1038/leu.2011.153. Epub 2011 Jun 17.

PMID:
21681188
11.

Induction of histiocytic sarcoma in mouse skeletal muscle.

Liu J, Hettmer S, Milsom MD, Hofmann I, Hua F, Miller C, Bronson RT, Wagers AJ.

PLoS One. 2012;7(8):e44044. doi: 10.1371/journal.pone.0044044. Epub 2012 Aug 31.

12.

Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l.

Chen L, Deshpande AJ, Banka D, Bernt KM, Dias S, Buske C, Olhava EJ, Daigle SR, Richon VM, Pollock RM, Armstrong SA.

Leukemia. 2013 Apr;27(4):813-22. doi: 10.1038/leu.2012.327. Epub 2012 Nov 9.

13.

Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in acute myeloid leukemia.

Röhrs S, Dirks WG, Meyer C, Marschalek R, Scherr M, Slany R, Wallace A, Drexler HG, Quentmeier H.

Mol Cancer. 2009 Oct 16;8:86. doi: 10.1186/1476-4598-8-86.

14.

RAS oncogene suppression induces apoptosis followed by more differentiated and less myelosuppressive disease upon relapse of acute myeloid leukemia.

Kim WI, Matise I, Diers MD, Largaespada DA.

Blood. 2009 Jan 29;113(5):1086-96. doi: 10.1182/blood-2008-01-132316. Epub 2008 Oct 24.

15.

ABI-1, a human homolog to mouse Abl-interactor 1, fuses the MLL gene in acute myeloid leukemia with t(10;11)(p11.2;q23).

Taki T, Shibuya N, Taniwaki M, Hanada R, Morishita K, Bessho F, Yanagisawa M, Hayashi Y.

Blood. 1998 Aug 15;92(4):1125-30.

16.

Generation and characterization of bioluminescent xenograft mouse models of MLL-related acute leukemias and in vivo evaluation of luciferase-targeting siRNA nanoparticles.

Fazzina R, Lombardini L, Mezzanotte L, Roda A, Hrelia P, Pession A, Tonelli R.

Int J Oncol. 2012 Aug;41(2):621-8. doi: 10.3892/ijo.2012.1504. Epub 2012 May 31.

PMID:
22665135
17.

Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis.

Ono R, Nakajima H, Ozaki K, Kumagai H, Kawashima T, Taki T, Kitamura T, Hayashi Y, Nosaka T.

J Clin Invest. 2005 Apr;115(4):919-29. Epub 2005 Mar 10.

18.

The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis.

Luo RT, Lavau C, Du C, Simone F, Polak PE, Kawamata S, Thirman MJ.

Mol Cell Biol. 2001 Aug;21(16):5678-87.

19.

Menin critically links MLL proteins with LEDGF on cancer-associated target genes.

Yokoyama A, Cleary ML.

Cancer Cell. 2008 Jul 8;14(1):36-46. doi: 10.1016/j.ccr.2008.05.003.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk